J Korean Med Assoc.  2014 Jan;57(1):9-11. 10.5124/jkma.2014.57.1.9.

Diagnosis and treatment of tuberculosis that we need to know as clinicians

• Kim HJ

• KMID: 2194828
• DOI: http://doi.org/10.5124/jkma.2014.57.1.9

Abstract

No abstract available.

MeSH Terms

Diagnosis*
Tuberculosis*

Reference

1. Korea Centers for Disease Control and Prevention. Annual report on the notified tuberculosis in Korea. Cheongwon: Korea Centers for Disease Control and Prevention;2012.

2. Joint Committee for the Development of Korean Guideline for Tuberculosis. Korean Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 1st ed. Cheongwon: Korea Centers for Disease Control and Prevention;2011.

3. World Health Organizaton. Global tuberculosis report 2013. Geneva: World Health Organizaton;2014.

4. Trajman A, Steffen RE, Menzies D. Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence. Pulm Med. 2013; 2013:601737.

5. Lewinsohn DA, Lobato MN, Jereb JA. Interferon-gamma release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children. Curr Opin Pediatr. 2010; 22:71–76.

6. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Geneva: World Health Organizaton;2011.

7. World Health Organizaton. Guidelines for the programmatic management of drug-resistant tuberulosis: 2011 update. Geneva: World Health Organizaton;2011.

8. Van Deun A, Maug AK, Salim MA, Das PK, Sarker MR, Daru P, Rieder HL. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2010; 182:684–692.

9. Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee D, Kim CT, Dartois V, Park SK, Cho SN, Barry CE 3rd. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med. 2012; 367:1508–1518.